A detailed history of Avion Wealth transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Avion Wealth holds 13 shares of REGN stock, worth $9,536. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13
Previous 11 18.18%
Holding current value
$9,536
Previous $11,000 18.18%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$1024.09 - $1201.76 $2,048 - $2,403
2 Added 18.18%
13 $13,000
Q2 2024

Jul 26, 2024

BUY
$883.2 - $1071.19 $883 - $1,071
1 Added 10.0%
11 $11,000
Q1 2024

May 03, 2024

BUY
$902.69 - $993.35 $3,610 - $3,973
4 Added 66.67%
10 $10,000
Q4 2023

Jan 26, 2024

SELL
$775.18 - $881.7 $1,550 - $1,763
-2 Reduced 25.0%
6 $5,000
Q3 2023

Oct 20, 2023

BUY
$692.45 - $844.37 $2,769 - $3,377
4 Added 100.0%
8 $5,000
Q2 2023

Jul 14, 2023

BUY
$700.03 - $830.35 $2,800 - $3,321
4 New
4 $2,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $78.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Avion Wealth Portfolio

Follow Avion Wealth and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avion Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Avion Wealth with notifications on news.